Currently, there are 3.22B common shares owned by the public and among those 2.80B shares have been available to trade.
The company’s stock has a 5-day price change of -0.51% and -48.17% over the past three months. TSLA shares are trading -38.41% year to date (YTD), with the 12-month market performance up to 45.17% higher. It has a 12-month low price of $138.80 and touched a high of $488.54 over the same period. TSLA has an average intraday trading volume of 88.46 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.01%, -25.83%, and -12.48% respectively.
Institutional ownership of Tesla Inc (NASDAQ: TSLA) shares accounts for 48.26% of the company’s 3.22B shares outstanding.
It has a market capitalization of $799.98B and a beta (3y monthly) value of 2.63. The stock’s trailing 12-month PE ratio is 122.02, while the earnings-per-share (ttm) stands at $2.04. The company has a PEG of 4.61 and a Quick Ratio of 1.61 with the debt-to-equity ratio at 0.19. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.82% over the week and 6.70% over the month.
Analysts forecast that Tesla Inc (TSLA) will achieve an EPS of 0.47 for the current quarter, 0.63 for the next quarter and 3.61 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.24 while analysts give the company a high EPS estimate of 0.24. Comparatively, EPS for the current quarter was 0.45 a year ago. Earnings per share for the fiscal year are expected to increase by 13.87%, and 36.87% over the next financial year.
Looking at the support for the TSLA, a number of firms have released research notes about the stock. Piper Sandler stated their Overweight rating for the stock in a research note on March 20, 2025, with the firm’s price target at $500-$450. Cantor Fitzgerald coverage for the Tesla Inc (TSLA) stock in a research note released on March 19, 2025 offered a Overweight rating with a price target of $425. RBC Capital Mkts was of a view on March 18, 2025 that the stock is Outperform, while Wells Fargo gave the stock Underweight rating on March 14, 2025, issuing a price target of $135- $130. Guggenheim on their part issued Sell rating on March 12, 2025.
